Translational research study of NIVOlumab RE-adminiTration for UnResectable/recurreNt gaStric cancer
Not Applicable
Recruiting
- Conditions
- nresectable/recurrent gastric cancer
- Registration Number
- JPRN-UMIN000051044
- Lead Sponsor
- Aichi Cancer Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
According to the study "Prospective observational study of efficacy and safety in re-administration of nivolumab for unresectable advanced/recurrent gastric cancer"
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method